![]() |
![]() |
Legal status
Patent lapsed (non-payment of fees)
(51) | INT.CL. | C07D 403/12 | (2006.01) |
C07D 407/12 | (2006.01) | ||
C07D 409/12 | (2006.01) | ||
A61K 31/4155 | (2006.01) | ||
A61P 29/00 | (2006.01) |
(11) | Number of the document | 2668181 |
(13) | Kind of document | T |
(96) | European patent application number | 12700695.5 |
Date of filing the European patent application | 2012-01-20 | |
(97) | Date of publication of the European application | 2013-12-04 |
(45) | Date of publication and mention of the grant of the patent | 2014-11-05 |
(46) | Date of publication of the claims translation | 2015-02-25 |
(86) | Number | PCT/EP2012/050830 |
Date | 2012-01-20 |
(87) | Number | WO 2012/101043 |
Date | 2012-08-02 |
(30) | Number | Date | Country code |
11151876 | 2011-01-24 | EP |
(72) |
ANDERSKEWITZ, Ralf, DE
MARTYRES, Domnic, DE
OOST, Thorsten, DE
RIST, Wolfgang, DE
SEITHER, Peter, DE
|
(73) |
GB007, Inc.,
3013 Science Park Road, Suite 200, San Diego, CA 92121,
US
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Pirazolo junginiai, kaip CRTH2 antagonistai |
PYRAZOLE COMPOUNDS AS CRTH2 ANTAGONISTS |
Payment date | Validity (years) | Amount | |
2019-12-31 | 9 | 208.00 EUR |
Patent lapsed (non-payment of fees) | ||
Invalidation date | 2021-01-20 |